Skip to content

Clinical trials

Vulvar Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Vulvar Neoplasms Country / region: Italy Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20091
20131
20161
20171
20202
20211
20221
20232
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Unknown status4
Completed3
Not yet recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fondazione Policlinico Universitario Agostino Gemelli IRCCS4
Catholic University of the Sacred Heart2
National Cancer Institute, Naples2
Azienda Ospedaliera per l'Emergenza Canizzaro1
CNAO National Center of Oncological Hadrontherapy1
Centro di Riferimento Oncologico - Aviano1
European Organisation for Research and Treatment of Cancer - EORTC1
IRCCS Azienda Ospedaliero-Universitaria di Bologna1
Merck Sharp & Dohme LLC1
University Magna Graecia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Vulvar Neoplasms15
Ovarian Neoplasms4
Uterine Cervical Neoplasms4
Endometrial Neoplasms3
Bile Duct Neoplasms1
Breast Neoplasms1
Carcinoma1
Carcinoma, Hepatocellular1
Colonic Neoplasms1
Condylomata Acuminata1

Trials

Showing 51 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.